Pyridazinediones and their use in the treatment of neurological disorders
申请人:ZENECA LIMITED
公开号:EP0516297A1
公开(公告)日:1992-12-02
The present invention relates to pyridazino[4,5-b]quinolines,
and pharmaceutically useful salts thereof, which are excitatory amino acid antagonists and which are useful when such antagonism is desired such as in the treatment of neurological disorders. The invention further provides pharmaceutical compositions containing pyridazino[4,5-b]quinolines as active ingredient, and methods for the treatment of neurological disorders.